港股异动 | 骨科耗材概念股回落骨科等仍在消化集采降价风险龙头企业业绩和估值有望逐步修复

智通财经09-10

智通财经APP获悉，骨科耗材概念股集体回落，截至发稿，春立医疗(01858)跌5.35%，报6.72港元；爱康医疗(01789)跌4.7%，报3.65港元；微创医疗(00853)跌2.34%，报4.59港元。中泰证券指出，高值耗材板块分化显著，电生理等高景气赛道持续高增长趋势，但骨科等集采赛道仍在消化集采降价风险。该行指出，“应采尽采”趋势下，目前大部分高值耗材已陆续纳入国家或地方集采范围，降价...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2466090451?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-10 14:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466090451","market":"hk","top_or_hot":-1,"title":"港股异动 | 骨科耗材概念股回落 骨科等仍在消化集采降价风险 龙头企业业绩和估值有望逐步修复","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，骨科耗材概念股集体回落，截至发稿，春立医疗(01858)跌5.35%，报6.72港元；爱康医疗(01789)跌4.7%，报3.65港元；微创医疗(00853)跌2.34%，报4.59港元。中泰证券指出，高值耗材板块分化显著，电生理等高景气赛道持续高增长趋势，但骨科等集采赛道仍在消化集采降价风险。该行指出，“应采尽采”趋势下，目前大部分高值耗材已陆续纳入国家或地方集采范围，降价...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1181302.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 骨科耗材概念股回落 骨科等仍在消化集采降价风险 龙头企业业绩和估值有望逐步修复</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 骨科耗材概念股回落 骨科等仍在消化集采降价风险 龙头企业业绩和估值有望逐步修复\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-10 14:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1181302.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，骨科耗材概念股集体回落，截至发稿，春立医疗(01858)跌5.35%，报6.72港元；爱康医疗(01789)跌4.7%，报3.65港元；微创医疗(00853)跌2.34%，报4.59港元。中泰证券指出，高值耗材板块分化显著，电生理等高景气赛道持续高增长趋势，但骨科等集采赛道仍在消化集采降价风险。该行指出，“应采尽采”趋势下，目前大部分高值耗材已陆续纳入国家或地方集采范围，降价...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1181302.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1585","symbol_name":"昨日强势股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1181302.html","article_id":"2466090451","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466090451","pubTimestamp":1725951281,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"中泰证券指出，高值耗材板块分化显著，电生理等高景气赛道持续高增长趋势，但骨科等集采赛道仍在消化集采降价风险。从目前时点看，企业逐步适应新常态，电生理、骨科、人工晶体等多个领域高值耗材带量采购的影响逐步出清，相关龙头公司的业绩确定性和估值有望逐步修复。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1585":"昨日强势股","BK1100":"医疗保健设备","00853":"微创医疗","01789":"爱康医疗","BK1589":"北水核心资产","BK1583":"高瓴概念","01858":"春立医疗"},"translate_title":"Hong Kong stocks have changed, orthopedic consumables concept stocks have fallen, orthopedics and others are still digesting the risk of centralized procurement and price cuts, and the performance and valuation of leading companies are expected to gradually recover","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":0.9,"01789":0.9,"01858":0.9},"content_text":"智通财经APP获悉，骨科耗材概念股集体回落，截至发稿，春立医疗(01858)跌5.35%，报6.72港元；爱康医疗(01789)跌4.7%，报3.65港元；微创医疗(00853)跌2.34%，报4.59港元。中泰证券指出，高值耗材板块分化显著，电生理等高景气赛道持续高增长趋势，但骨科等集采赛道仍在消化集采降价风险。该行指出，“应采尽采”趋势下，目前大部分高值耗材已陆续纳入国家或地方集采范围，降价压力持续释放，相关品种国产中标份额提升显著，未来有望保持快速增长，建议重点关注集采即将出清的骨科龙头，同时看好电生理领域持续进口替代。中信建投指出，去年下半年至今，医疗板块大幅调整，主要医疗合规要求提升和多项医改政策复合影响的背景下，预计上市公司经营存在不确定性等因素有关。受去年下半年医疗合规性要求提升影响，去年下半年和今年上半年不少器械公司业绩增速放缓，由此导致板块有所调整。从目前时点看，企业逐步适应新常态，电生理、骨科、人工晶体等多个领域高值耗材带量采购的影响逐步出清，相关龙头公司的业绩确定性和估值有望逐步修复。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466090451"}

港股异动 | 骨科耗材概念股回落 骨科等仍在消化集采降价风险 龙头企业业绩和估值有望逐步修复

精彩评论

港股异动 | 骨科耗材概念股回落骨科等仍在消化集采降价风险龙头企业业绩和估值有望逐步修复